New version of the IKARpro!
We want to present you a new version of the IKARpro database. At the moment, at https://ikarpro.pl, its refreshed and richer version with ne...
HTA Consulting is a Polish company with long-time experience, specialising in health technology assessment for drugs, medical devices and diagnostic methods in Poland and worldwide. We analyse, advise and train in the field of legislative and systemic solutions, pricing, designing and implementing research for health care organisations and private institutions.
What is
OUR MISSION
It is our mission to seek the truth using scientific research methods. With our experience and know-how we support taking rational and evidence-based decisions in health care. We do not engage in, have not engaged in nor do we intend to engage in any activities related to lobbying in favour of or against any company manufacturing medicinal products, medical devices or medical supplies.
We Have
THE STORY BEHIND OUR COMPANY
HTA Consulting was established in 2001 in Krakow and pioneers in health technology assessment studies both in Poland and in Central and Eastern Europe. At present the primary activity of HTA Consulting is conducting assessments of safety, efficacy and costs of alternative treatment options in line with best credibility criteria adopted worldwide, i.e. Evidence-Based Health Care... [ read more ]
500
HTA REPORTS
70
CLIENTS ALL OVER THE WORLD
15
YEARS OF EXPERIENCE
Our Offer
HTA Consulting is an expertise company with extensive experience and proven credibility in health technology assessment. It is regarded as a trusted partner for many worldwide health care companies expecting high quality analysis and strategic advisory with a rational assessment of the opportunities offered by the product. The unique team of interdisciplinary experts connecting scientific approach and business spirit stays at the core of the company’s success.
Latest News
July 30, 2018
July 18, 2018Dr. M. Władysiuk for PZ: there is no national plan of rare diseases
Dr Magdalena Władysiuk, Vice President of HTA Consulting, gave an interview for Health Policy about the lack of a national plan for rare di...
July 10, 2018Potential overrun of the budget for reimbursement
The NFZ has published a statement regarding the costs of the total budget for reimbursement from January to May 2018. The percentage of imp...
June 28, 2018Vaccine VaxigripTetra® placed on the reimbursement list
Quadrivalent influenza vaccine (split virion), inactivated – VaxigripTetra® has been placed on the list of reimbursed drugs (Project ...
Our Partners
Contact
If you have any question, do not hesitate to ask our representatives.
ul. Starowiślna 17/3
31-038 Kraków, POLAND
phone (+48) 12 421 88 32
mobile (+48) 508 180 859
fax (+48) 12 395 38 32
NIP 675-12-67-600